Victory Square Intensifies Push Into Healthcare Infrastructure With Hydreight-Led Strategy

Victory Square Technologies Inc ( (TSE:VST) ) has shared an announcement.

Victory Square Technologies is sharpening its focus on healthcare infrastructure in 2026, leveraging its ecosystem of physician networks, pharmacies, telehealth platforms, and compliance frameworks to tackle the fragmentation of the U.S. healthcare market. The company aims to position its digital health and biotech holdings as key enablers of regulated, multi-state care delivery across areas such as metabolic health, longevity, and preventative care.

A central pillar of this strategy is the $10 million Digital Health Accelerator launched with Hydreight in early 2025 to onboard U.S. healthcare operators generating at least $750,000 in annual revenue onto the VSDHOne platform. The program offers 50‑state telehealth rails, physician integration, pharmacy enablement, workflow automation, and regulatory support, while also serving as a deal pipeline for prospective licensees and brands that can expand the broader ecosystem.

Hydreight, Victory Square’s largest operating subsidiary, continues to anchor the group’s healthcare thesis by operating a vertically integrated infrastructure platform for compliant, multi-state care. The business has issued fiscal 2026 revenue guidance of about $150 million and expects to realize operating leverage through an anticipated adjusted EBITDA margin in the mid‑teens range, underscoring management’s confidence in scaling transaction volumes without materially increasing fixed costs.

Management argues that the regulatory complexity of the U.S. healthcare system, including state-specific licensing and telehealth rules, creates durable barriers to entry that favor operators with robust, integrated infrastructure. By combining Hydreight’s national compliance and distribution capabilities with complementary platforms such as Insu Therapeutics’ oral peptide delivery technology, Victory Square is seeking to build a layered healthcare ecosystem that can support scalable programs across multiple therapeutic categories and deepen its positioning in a large, structurally inefficient market.

The most recent analyst rating on (TSE:VST) stock is a Hold with a C$0.60 price target. To see the full list of analyst forecasts on Victory Square Technologies Inc stock, see the TSE:VST Stock Forecast page.

Spark’s Take on TSE:VST Stock

According to Spark, TipRanks’ AI Analyst, TSE:VST is a Underperform.

The score is held down primarily by weak financial performance (losses, negative ROE, and negative operating cash flow) despite strong revenue growth. Technical indicators also lean bearish with the price below key moving averages and negative MACD. Valuation provides limited support due to a negative P/E and no dividend yield data.

To see Spark’s full report on TSE:VST stock, click here.

More about Victory Square Technologies Inc

Victory Square Technologies Inc. is a Vancouver-based technology investment company focused on building and scaling digital health, biotech, pet health, diagnostics, and immersive technology platforms. Through majority-owned subsidiary Hydreight Technologies and the VSDHOne platform, it targets the fragmented North American healthcare market by providing compliant, multi-state healthcare infrastructure and digital rails to support scalable care delivery for diverse therapeutic categories.

Average Trading Volume: 133,356

Technical Sentiment Signal: Buy

Current Market Cap: C$62.56M

See more insights into VST stock on TipRanks’ Stock Analysis page.